Risperidone: Treatment response in adult and geriatric patients

International Journal of Psychiatry in Medicine

Volumn 28, Issue 2, 1998, Pages 255-263

  Kiraly, S J ^a,e   Gibson, R E ^b   Ancill, R J ^c   Holliday, S G ^d  

^a Adult Mental Health Services   (Canada)

^b GVMHSS ^*

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d St Vincent's Hospital

^e GVMHSS   (Canada)

Author keywords

Atypical neuroleptics; Behavior syndromes; Dementia; Geriatric psychiatry; Paranoid disorders; Paraphrenia; Psychosis; Risperidone; Schizophrenia

Indexed keywords

RISPERIDONE;

ADULT; AGED; ARTICLE; DELUSION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; SCHIZOPHRENIA; SCORING SYSTEM; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0031848358     PISSN: 00912174     EISSN: None     Source Type: Journal    
DOI: 10.2190/APJP-Y8R6-14GM-K1YT     Document Type: Article

References (22)

1. Hoyberg OJ, Fensbo C, Remvig J, Lingjaerde O, Sloth-Nielsen M, Salvesen I. Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations. Acta Psychiatr Scandinavia 1993;88:395-402.
2. Peuskens, J. Risperidone in the treatment of patients with chronic schizophrenia: A multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. British Journal of Psychiatry 1995;6:712-726.
3. Mertens C. Risperidone in psychogeriatric patients with behavioural disturbances in open long-term follow-up study. Janssen Research Foundation Report, Clinical Research Report RIS-BEL-13, 1990.
4. Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Amott W. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. Journal of Clinical Psychopharmacology 1993;13(1):25-40.
5. Heylen SLE, Gelders YG, Bussche V. Risperidone (R 64 766) in the treatment of behavioural symptoms in psychogeriatric patients: Pilot clinical investigation. Internationl Symposium of Psychogeriatrics 1988, April 28-29, Lausanne, Switzerland.
6. Heylen SLE, Gelders YG. Risperidone in the treatment of behavioural disturbances in psychogeriatric patients: A multicenter open dose-finding study. Part I: Clinical Report Janssen Research Foundation Report 1989, Clinical Research Report R 64 766/19.
7. Prado P, Kramer-Ginsberg E, Kremen N, Hanan P, Safferman AZ. Risperidone in dementia with behavioural disturbances. 148th Meeting of the American Psychiatric Association 1995, May 20-25, Miami, Florida, p. 55.
8. Goldberg RJ, Goldberg JS. Low-dose risperidone for dementia related disturbed behaviour in nursing homes. Clinical Geriatrics 1996;4(2):58-68.
9. Evans EG. Risperidone in institutionalized psychotic patients unresponsive to conventional antipsychotic agents. 148th Meeting of the American Psychiatric Association 1995, May 20-25, Miami, Florida, p. 187.
10. Aronson SM, Lingam VS, Hasanat KA. Risperidone in geropsychiatry: Review of Experience in Two Teaching Public Hospitals. 148th Meeting of the American Psychiatric Association 1995, May 20-25, Miami, Florida, p. 127.
11. Lee H, Cooney JM, Lawlor BA. The use of risperidone, an atypical neurolepic, in Lewy body disease. International Journal of Geriatric Psychiatry 1994;9:415-417.
12. Howard R, Meehan O, Powell R, Mellers J. Successful treatment of Charles Bonnet syndrome type visual hallucinations with low-dose risperidone. International Journal of Geriatric Psychiatry 1994;9(8):677-678.
13. Jeste DV, Eastham JH, Lacro JP, Gierz M, Field MG, Harris MJ. Management of late-life psychosis. Journal of Clinical Psychiatry 1994;57(Suppl 3):39-45.
14. Davidson M, Berman I, Keefe RS, Duvvi K, Pontecorvo M. Risperidone in elderly schizophrenic patients. Schizophrenia Research 1994;11(2) (Special Issue) 197.
15. Madhusoodanan S, Brenner R, Araujo L, Abaza A. Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder or senile dementia in 11 geriatric patients: A case series. Journal of Clinical Psychiatry 1995;56(11):514-518.
16. McKeith IG, Ballard CG, Harrison RWS. Neuroleptic sensitivity to risperidone in Lewy body dementia. Lancet 1995;346:699.
17. Wittgens W, Donath O, Klieser E, Trenckmann U. Paranoid symptoms in dementia treated with risperidone. Campaign on Schizophrenia 1995, March 10-12, Florence, Italy, p. 185.
18. Jeanblanc W, Battey-Davis Y. Risperidone for treating dementia-associated aggression. American Journal of Psychiatry 1995;152(8):1239.
19. Ancill RJ, Nielsen RJ. Psychosis in the Elderly. In: Holliday SG, Ancill RJ, MacEwan GS, editors. Schizophrenia: Breaking Down the Barriers. Chichester, England: John Wiley & Sons Ltd, 1996:237-242.
20. Sajatovic M, Ramirez LF, Vernon L, Brescan D, Simon M, Jurjus G. Outcome of risperidone therapy in elderly patients with chronic psychosis. International Journal of Psychiatry in Medicine 196;26(3):309-317.
21. Guy W. (1976) ECDEU Assessment Manual for Psychopharmacology (revised) National Institute of Mental Health, Published by DHEW, 1975; No (ADM) 76-338, Rockville, MD.
22. Janssen Pharmaceutica Inc. Product Monograph 1995 (revision March 22, 1995), Mississauga, Ontario, Canada, p. 9.